UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Fairman Group LLC

Fairman Group LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 57.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 92 shares of the healthcare conglomerate’s stock after selling 125 shares during the period. Fairman Group LLC’s holdings in UnitedHealth Group were worth $48,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. IAG Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group during the first quarter worth $42,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $41,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $280.69 on Monday. The business’s 50-day simple moving average is $301.58 and its 200-day simple moving average is $424.22. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The firm has a market cap of $254.62 billion, a price-to-earnings ratio of 11.75, a P/E/G ratio of 1.39 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 3.15%. UnitedHealth Group’s dividend payout ratio is presently 37.02%.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The stock was purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer directly owned 203,796 shares in the company, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock worth $31,607,768 over the last 90 days. Company insiders own 0.28% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on UNH shares. TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a research report on Monday, May 19th. TD Securities reissued a “hold” rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Bank of America downgraded UnitedHealth Group from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, Oppenheimer reduced their price objective on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $392.29.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.